+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Trastuzumab"

HER2 Inhibitors Global Market Report 2024 - Product Thumbnail Image

HER2 Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Trastuzumab Biosimilars Global Market Report 2024 - Product Thumbnail Image

Trastuzumab Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Breast Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Breast Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
HER2 Positive Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2 Positive Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
From
From
Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 100 Pages
  • Global
From
From
Trastuzumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Trastuzumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

Trastuzumab is a monoclonal antibody used to treat certain types of breast cancer. It is used to treat HER2-positive breast cancer, which is a type of cancer that has a higher than normal amount of a protein called HER2. Trastuzumab works by blocking the HER2 protein, which helps to slow or stop the growth of cancer cells. It is usually given in combination with other chemotherapy drugs. Trastuzumab is typically given intravenously, and can be used in both early and advanced stages of breast cancer. It is also used to reduce the risk of recurrence in patients who have already been treated for HER2-positive breast cancer. Trastuzumab is a widely used drug in the treatment of breast cancer, and is available from a number of pharmaceutical companies. Some of the companies that produce trastuzumab include Roche, Merck, Pfizer, and Amgen. Show Less Read more